ABSTRACT Human T lymphocyte subpopulations recently have been defined by monoclonal antibodies that recognize cellsurface antigens selectively expressed on functionally distinct T cell subsets. The majority (approximately 90%) of the peripheral blood sheep erythrocyte-rosette-forming cells carry the tigen. Helper cells are OKT4', whereas cytotoxic/suppressor cells are OKT5' and OIT8+. We investigated the effect of several monoclonal antibodies recognizing T cell antigens on certain proliferative responses ofT cells and on the effector phase of the speL cific T cell-mediated cytotoxicity generated in mixed lymphocyte culture (MLC). In the absence ofadded complement, (i) OKT3 and OKT4 monoclonal antibodies inhibited the proliferative response to phytohemagglutinin (PHA), (it) OKT3 monoclonal antibody inhibited the proliferative response to allogeneic cells in MLC, and (iii) OKT3 monoclonal antibody significantly and regularly inhibited the effector phase of the specific T cell-mediated cytotoxicity against allogeneic targets (P < 0.001) in a concentration-dependent manner. The OKT5 and OKT8 monoclonal antibodies, again in the absence of complement, inhibited moderately the specific cell-mediated cytotoxicity. This inhibition was observed in some experiments only. Inhibition of the specific cytotoxicity by these antibodies also was observed in secondary responses. In contrast, again in the absence of added complement, none of these antibodies had an effect on the nonspecific cytotoxicity generated in MLC against the K562 targets. The OKT4 antibody in the absence of added complement had no effect on either the specific or nonspecific cytotoxicity. Furthermore, treatment with OKT3 or OKT8 antibody and complement completely abrogated the specific T cell-mediated cytotoxicity but had no effect on the natural Idllerlike cytotoxicity against the K562 cells. Treatment with the OKT4 antibody and complement had no effect. These results suggest that (i) the T5/T8 and T3 antigens, present on cytotoxic T lymphocytes, may be involved directly or indirectly in the antigen recognition step(s) or the lytic mechanism of T cell-mediated lympholysis; and (ii) nonspecific cytotoxicity against the K562 targets generated in MLC is mediated by cells phenotypically different than those that mediate specific cytotoxicity.
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Human T lymphocytes and their subpopulations have been defined by monoclonal antibodies that recognize cell surface differentiation antigens selectively expressed on functionally distinct T cell subsets (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (4, 5) . These two populations correspond to that previously defined by heteroantisera TH2-helper and TH2' cytotoxic populations (12, 13) . Furthermore, both the OKT4 and OKT5 subpopulations carry the OKT1 and OKT3 antigens, defined by corresponding monoclonal antibodies (1, 10) . The subpopulation defined by the OKT5 and OKT8 monoclonal antibodies contains all of the cytotoxic cell precursors and effectors in T cell-mediated cytotoxicity. Furthermore, these cells suppress the differentiation of B cells to immunoglobulin-synthesizing and -secreting plasma cells in the pokeweed mitogen-induced system (14) . Inducer T lymphocytes, defined by the OKT4 antibody, provide helper activity for the differentiation of B cells to plasma cells (3) and are required for optimal generation ofcytotoxicity by the OKT5/ OKT8 population (4, 5) .
These surface antigens on human T cells are generally analogous to the murine Lyt-1 and Lyt-2,3 system. Murine helper cells are Lyt-l and -2,3-, whereas cytotoxic cells are Lyt-1-and -2,3+ according to initial reports (15) or Lyt-l and -2,3+ according to other investigators (16) (17) (18) . After initial unsuccessful attempts (16, 19) , several investigators have reported inhibition ofspecific T cell-mediated lympholysis in the absence of added complement by anti-Lyt-2 and anti-Lyt-3 (but not aLyt-1) antibodies at the effector cell level (18, 20, 21) . Furthermore, it has been reported that genes for K light chain and genes for the Lyt-2 and Lyt-3 antigens are closely linked on chromosome 6 (22) (23) (24) , which suggests the possibility that the Lyt-2 antigen is either adjacent to T cell receptors on the cell surface (and monoclonal antibodies inhibit by steric hydrance interactions) or is part of the antigen receptor structure. It has been suggested that the antigen receptor ofthe cytotoxic T cell may be composed of Lyt-2 determinants as a constant portion and VK determinants as a variable region (21) .
These results in the mouse and the reports on the close linkage between Lyt-2 genes and K chain genes prompted us to investigate the effect of several monoclonal antibodies defining human T cell antigens on certain proliferative responses of T cells and on the effector phase of the specific T cell-mediated cytotoxicity against allogeneic targets in the absence of added complement. We observed: (i) inhibition of proliferative T cell responses by certain ofthese antibodies, (ii) significant and consistent inhibition of the specific cell-mediated cytotoxicity by the OKT3 monoclonal antibody, and (iii) moderate inhibition of the specific cytotoxicity by the OKT5 and OKT8 monoclonal antibodies.
MATERIAL AND METHODS Preparation of Monoclonal Leukocytes. Peripheral blood mononuclear leukocytes were prepared by centrifugation on a Ficoll/Hypaque density cushion as described (25) .
Abbreviations: PHA, phytohemagglutinin; Con A, concanavalin A; MLC, mixed lymphocyte culture.
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Monoclonal Antibodies. OKT3. PAN, OKT4. IND, and OKT8. SUP monoclonal antibodies were purchased from Ortho Pharmaceuticals (Raritan, NJ). The antibodies were reconstituted with distilled water and were extensively dialyzed (three times) against phosphate-buffered saline. Titers were determined by a standard indirect immunofluorescence method. OKT5. SUP antibody was kindly provided by G. Goldstein and P. Kung of Ortho. An anti-DR monoclonal antibody was obtained from Accurate Chemical, Westbury, NY.
Proliferative Responses to Mitogens and Allogeneic Cells in Mixed Lymphocyte Culture (MLC). Peripheral blood mononuclear leukocytes (1 x 106 cells per ml) were cultured in RPMI-1640 medium (GIBCO) supplemented with 20% (vol/ vol) fetal calf serum (GIBCO), 2 mM glutamine (GIBCO), 25 mM Hepes, and 100 units of penicillin and 100 ,ug of streptomycin per ml, with either phytohemagglutinin (PHA; 10 ,ug/ ml; GIBCO) or concanavalin A (Con A; 25 pg/ml; Pharmacia) in U-bottom microtiter plates (Nunc, Copenhagen) at 370C in a humidified incubator in 5% C02/95% air. The cultures were pulsed after 3 days with 2 puCi (1 Ci = 3.7 X 1010 becquerels) of [3H]thymidine (New England Nuclear; specific activity, 6.7 Ci/mmol) per ml and harvested 24 hr later with an automatic cell harvester.
MLCs were prepared by placing responding cells (2 x 105) and irradiated (2000 R) stimulating cells (2 X 105) (total volume, 0.2 ml) in round-bottom microtiter plates and culturing for 6 days. The cultures were pulsed with [3H]thymidine on the fifth day and harvested as described (25) . Various concentrations of monoclonal antibodies were added to the cultures before the addition of the mitogens or the stimulating cells.
Treatment of the Cells with Antibody and Complement. MLC blasts were treated with antibody and complement by a standard two-step protocol as described (26) . Rabbit complement was obtained from Pel Freeze (Little Rock, AR). The cells were washed four times with Hank's balanced salt solution supplemented with 10% fetal calfserum before the cytotoxic assays.
Specific Cell-Mediated Cytotoxicity. Cytotoxic T lymphocytes were generated by culturing 10 x 106 peripheral blood mononuclear leukocytes (responding cells) with 10 x 106 irradiated (2000 R) allogeneic peripheral blood mononuclear cells (stimulating cells) at a final cell concentration of 2 X 106 cells per ml in RPMI-1640 medium supplemented with 10% heatinactivated fetal calf serum (GIBCO), 25 mM Hepes buffer, 2 mM glutamine, and 100 units of penicillin and 100 ,ug of streptomycin per ml. The cells were incubated in tissue culture flasks (Falcon, 3013) in humidified 5% C02/95% air for 7 days. Nonirradiated stimulating cells (1 x 106 cells per ml) were cultured in the medium and stimulated with 10 ,ug of PHA per ml for the last 4 days of the incubation. Alternatively, in other experiments stimulating cells were cultured with pokeweed mitogen (PWM; 10 ,ug/ml, GIBCO) and erythrocyte-rosette-negative (non-T) cells were prepared by rosetting with sheep erythrocytes (25) and used as target cells in the cytotoxicity assay. On the day of the assay, 1 x 106 target cells were centrifuged at 200 X g for 5 min, resuspended in 0.3 ml of medium, and labeled with 250 ,uCi of Na 52CrO4 (specific activity 200-500 mCi/mg of Cr; New England Nuclear) for 1-1.5 hr at 37°C. The target cells were washed three times with medium and resuspended at a concentration of 5 x 104 cells per ml. Effector cells were washed twice and incubated at room temperature for 30 min with various concentrations of monoclonal antibodies as described. Aliquots of 100 ,u1 were mixed with 100 ,ul oftarget cells in round-bottom microtiter plates (Nunclon, Copenhagen, Denmark) and incubated for 5 hr at 370C in humidified 5% C02/ 95% air. Supernatants (100 dul each) were carefully withdrawn, and radioactivity was assayed in a y counter (Packard Instruments). Percentage cytotoxicity was determined as follows: % specific lysis = experimental release -spontaneous release maximum release -spontaneous release x 100.
Maximum release was determined by treating 100 u1 of target cells with 100 ttl of 5% (vol/vol) Triton X-100 for 5 hr at 370C.
Spontaneous release was determined by incubating target cells in medium alone for 5 hr at 370C. Secondary MLCs were established by culturing 5 x 106 cells from the primary MLC with 15 X 106 stimulating cells at a concentration of 2 x 106 cells per ml for 3 days. Cell-mediated cytotoxicity against PHA-treated blasts autologous to the stimulating cells was determined as described.
Natural Killer-Like Cytotoxicity. Nonspecific or natural killer-like cytotoxicity of MLC allosensitized cells against the K562 targets was determined as described (27) .
RESULTS
The effect of the OKT3, OKT4, OKT5, and OKT8 monoclonal antibodies, in the absence of added complement, on the proliferative response of mononuclear peripheral blood leukocytes to PHA and Con A is shown in Fig. 1 Top and Middl. The antibodies were added to the cultures before the addition of the mitogens. OKT3 and OKT4 monoclonal antibodies inhibited the proliferative response to PHA. OKT5 and OKT8 antibodies did not cause statistically significant inhibition. In the absence ofadded complement, each antibody inhibited at high concentrations the proliferative response to Con A ( Fig. 1 Middle) ; furthermore, the OKT3 monoclonal antibody added from the beginning of the mixed lymphocyte culture inhibited the proliferative response to allogeneic cells (Fig. 1 Bottom) . In the absence ofadded complement, the OKT3 monoclonal antibody resulted in significant inhibition of the effector phase of the specific T cell-mediated cytotoxicity against allogeneic PHA-treated blasts (P < 0.001) ( Table 1 ). OKT8 monoclonal antibody inhibited moderately the specific T cell-mediated cytotoxicity. This inhibition was statistically significant (P < 0.005) for the eight experiments shown in Table 1 . However, significant inhibition was observed only in some experiments. Similar results were obtained with the OKT5 monoclonal antibody (Fig.  2) , which inhibited moderately in certain experiments. In contrast, addition ofthe OKT4 antibody or control ascites fluid had no effect on the specific cell-mediated cytotoxicity (Table 1) . A representative experiment demonstrating the dependence of the inhibition on the antibody concentration is shown in Fig.  2 . Furthermore, addition of an anti-DR monoclonal antibody (nonpolymorphic), in the absence of added complement, had no effect on the specific T cell-mediated cytotoxicity (Table 2 , Fig. 2) .
Inhibition of the specific cell-mediated cytotoxicity by the OKT3, OKT5, and OKT8 monoclonal antibodies after restimulation in secondary MLC was also observed in the absence of added complement (data not shown).
In contrast to the inhibition of the effector phase of the specific cytotoxicity by these monoclonal antibodies, these reagents had no effect on the nonspecific (natural killer-like) cytotoxicity Monoclonal antibody, Ag/ml
FIG. 2. Effect of OKT3 (a-.), OKT4 (_-_), OKT5 (o-o), OKT8 (A-A-A)
, and anti-DR (n-n) monoclonal antibodies, in the absence ofadded complement, on the specific cell-mediated cytotoxicity against purified sheep erythrocyte-rosette-negative targets. generated. in MLC against the K562 targets (Table 3 ) (28) (29) (30) .
The effect of these antibodies on the natural killer-like cytotoxicity was determined on days 5 and 7 ofthe M LCs with identical results.
In other experiments we determined the cell-surface phenotypes of the cytotoxic cells by in vitro treatment with the corresponding monoclonal antibodies and complement. In vitro treatment with the OKT3 or OKT8 antibodies and complement completely. abrogated the specific T cell-mediated cytotoxicity against allogeneic PHA-treated blasts but had no effect on the nonspecific cytotoxicity against the K562 targets (Table 4) . OKT4 antibody and complement treatment in vitro was ineffective against either the specific or nonspecific cytotoxicity.
DISCUSSION
We investigated the effect of certain monoclonal antibodies, specific for human T cell antigens, on the proliferative response to mitogens and to allogeneic cells in MLC and on the specific T cell-mediated cytotoxicity against allogeneic targets. In the absence of added complement, OKT3 and OKT4 monoclonal antibodies inhibited the proliferative response to PHA. In con- In other experiments in the absence of added complement, we observed that the OKT3 monoclonal antibody significantly inhibited the effector phase of the specific cell-mediated cytotoxicity against allogeneic PHA blasts or purified non-T cells. The OKT5 and OKT8 monoclonal antibodies inhibited moderately the specific cell-mediated cytotoxicity in certain experiments. Nonspecific cytotoxicity (against K562 targets) generated by was not inhibited by these monoclonal antibodies either in the presence or in the absence of added complement, which suggests that the effector cells in specific T cell-mediated cytotoxicity are different from the effector cells in the natural killer-like cytotoxicity. It appears that the latter cells do not carry thymus-dependent antigens identifiable by the antibodies studied here.
The mechanism of inhibition of the specific T cell-mediated cytotoxicity by these monoclonal antibodies is not clear.
Explanation of the inhibition of cytotoxicity by the OKT3 monoclonal antibody is complicated. In consideration of our other results, which show that the OKT3 antibody blocks the proliferative responses to mitogens (PHA and Con A) or to allogeneic cells in MLC, it appears that the recognized antigen is a unique structure on the cell membrane and may be involved in several cell functions. "Inactivation" or blocking of this antigen by the OKT3 antibody may cause impairment ofa number ofcell functions. However, the possibility that inhibition of the specific T cell-mediated cytotoxicity by these antibodies may function through nonspecific means (as agglutination, modulation, or redistribution of cell-surface antigens or inhibition of cell motility) appears unlikely, although such nonspecific interactions cannot be entirely-excluded at the present. We have shown that an anti-Ia monoclonal antibody does not inhibit the specific cytotoxicity in the absence of added complement. This antibody recognizes Ia antigens present on MLC blasts (31) (32) (33) . Their distribution and density on the cell surface may be equivalent to that of the OKT3 and OKT5/OKT8 antigens.
In experiments reported elsewhere (9) (34) . Anti-Leu-2a and anti-Leu-2b monoclonal antibodies recognize under nonreducing conditions a 70,000-dalton antigen, which in reduced polyacrylamide gels is dissolved into two subunits of 30,000 and 43,000 daltons (34) . Similarly the OKT5 antibody recognizes an antigen of 76,000 daltons, which under reducing conditions is dissolved into two subunits of 30,000 and 32,000 daltons (35) .
Anti-Leu-3a and anti-Leu-3b monoclonal antibodies (which define helper cells) did not inhibit the specific cytotoxicity (9) . Furthermore, in contrast to the anti-OKT3 antibody, anti-Leu-1 antibody (8) also did not inhibit the specific cytotoxicity (9) .
Inhibition ofspecific T cell-mediated cytotoxicity by anti-Leu 2a, OKT5, and OKT8 monoclonal antibodies suggests that the recognized antigen is associated with molecules responsible for alloantigen recognition (antigen receptor) or involved directly or indirectly in the lytic mechanism. It appears that the anti-Leu 2a antibody recognizes an epitope more closely associated with the recognition mechanism or the lytic event than the epitopes recognized by the OKT5, OKT8, and anti-Leu 2b monoclonal antibodies. This explanation associates this antigen that is expressed selectively on cytotoxic effector cells and their precursors with the cytotoxic function per se. The other possibility is that this antigen is located on the cell membrane near the T cellantigen receptor. In this case, these antibodies may inhibit cytotoxicity by steric hindrance interactions. Furthermore, it is possible that this antigen is part of the T cell-antigen receptor complex. It has been found in the mouse that the Lyt-2 genes are closely linked to genes for K light chain (22) (23) (24) , and it has been suggested (21) that the murine T cell-antigen receptor may have a constant portion (Lyt-2) and a variable portion (VK). The constant and variable portions of the receptor complex may reside on two different molecules associated noncovalently with each other. Other investigators (34) (35) (36) 
